NDC Product
Human Prescription DrugPancreaze NDC 62541-401
- Generic Name
- Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Marketing
- BLA
Active Listing
Amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT Delayed Release Oral Capsule
RxNorm 2478453 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Amylase 15200 UNT / lipase 2600 UNT / protease 8800 UNT Delayed Release Oral Capsule (RxCUI 2478453). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
